Literature DB >> 26624554

Ending the HIV-AIDS Pandemic--Follow the Science.

Anthony S Fauci1, Hilary D Marston.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26624554     DOI: 10.1056/NEJMp1502020

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  29 in total

1.  Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection.

Authors:  Zaza M Ndhlovu; Samuel W Kazer; Thandeka Nkosi; Funsho Ogunshola; Daniel M Muema; Gursev Anmole; Shayda A Swann; Amber Moodley; Krista Dong; Tarylee Reddy; Mark A Brockman; Alex K Shalek; Thumbi Ndung'u; Bruce D Walker
Journal:  Sci Transl Med       Date:  2019-05-22       Impact factor: 17.956

2.  An enantioselective enzymatic desymmetrization route to hexahydro-4H-furopyranol, a high-affinity ligand for HIV-1 protease inhibitors.

Authors:  Arun K Ghosh; Anindya Sarkar
Journal:  Tetrahedron Lett       Date:  2017-07-03       Impact factor: 2.415

3.  Co-located Opioid Use Disorder and Hepatitis C Virus Treatment Is Not Only Right, But It Is Also the Smart Thing To Do as It Improves Outcomes!

Authors:  Sandra A Springer; Carlos Del Rio
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

Review 4.  The use of longitudinal cohorts for studies of dengue viral pathogenesis and protection.

Authors:  Leah C Katzelnick; Eva Harris
Journal:  Curr Opin Virol       Date:  2018-03-26       Impact factor: 7.090

5.  HIV-Associated Neurocognitive Disorder (HAND) and the Prospect of Brain-Penetrating Protease Inhibitors for Antiretroviral Treatment.

Authors:  Arun K Ghosh; Anindya Sarkar; Hiroaki Mitsuya
Journal:  Med Res Arch       Date:  2017-04-15

Review 6.  HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.

Authors:  Deanna Saylor; Alex M Dickens; Ned Sacktor; Norman Haughey; Barbara Slusher; Mikhail Pletnikov; Joseph L Mankowski; Amanda Brown; David J Volsky; Justin C McArthur
Journal:  Nat Rev Neurol       Date:  2016-03-11       Impact factor: 42.937

7.  A Photochemical Route to Optically Active Hexahydro-4H-furopyranol, a High-Affinity P2 Ligand for HIV-1 Protease Inhibitors.

Authors:  Arun K Ghosh; William L Robinson
Journal:  J Org Chem       Date:  2019-07-16       Impact factor: 4.354

8.  Assessing pharmacokinetic marker correlates of outcome, with application to antibody prevention efficacy trials.

Authors:  Peter B Gilbert; Yuanyuan Zhang; Erika Rudnicki; Yunda Huang
Journal:  Stat Med       Date:  2019-07-17       Impact factor: 2.373

9.  Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).

Authors:  Dan H Barouch; Frank L Tomaka; Frank Wegmann; Daniel J Stieh; Galit Alter; Merlin L Robb; Nelson L Michael; Lauren Peter; Joseph P Nkolola; Erica N Borducchi; Abishek Chandrashekar; David Jetton; Kathryn E Stephenson; Wenjun Li; Bette Korber; Georgia D Tomaras; David C Montefiori; Glenda Gray; Nicole Frahm; M Juliana McElrath; Lindsey Baden; Jennifer Johnson; Julia Hutter; Edith Swann; Etienne Karita; Hannah Kibuuka; Juliet Mpendo; Nigel Garrett; Kathy Mngadi; Kundai Chinyenze; Frances Priddy; Erica Lazarus; Fatima Laher; Sorachai Nitayapan; Punnee Pitisuttithum; Stephan Bart; Thomas Campbell; Robert Feldman; Gregg Lucksinger; Caroline Borremans; Katleen Callewaert; Raphaele Roten; Jerald Sadoff; Lorenz Scheppler; Mo Weijtens; Karin Feddes-de Boer; Daniëlle van Manen; Jessica Vreugdenhil; Roland Zahn; Ludo Lavreys; Steven Nijs; Jeroen Tolboom; Jenny Hendriks; Zelda Euler; Maria G Pau; Hanneke Schuitemaker
Journal:  Lancet       Date:  2018-07-06       Impact factor: 79.321

Review 10.  Mechanisms of neuropathogenesis in HIV and HCV: similarities, differences, and unknowns.

Authors:  Ameer Abutaleb; Sarah Kattakuzhy; Shyam Kottilil; Erin O'Connor; Eleanor Wilson
Journal:  J Neurovirol       Date:  2018-10-05       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.